Your browser doesn't support javascript.
loading
Atherosclerotic cardiovascular disease events among adults with high predicted risk without established risk factors.
Kong, Nathan; Sakhuja, Swati; Colantonio, Lisandro D; Levitan, Emily B; Lloyd-Jones, Donald M; Cushman, Mary; Muntner, Paul; Polonsky, Tamar S.
Afiliação
  • Kong N; Department of Medicine, University of Chicago, Chicago, IL, United States.
  • Sakhuja S; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, United States.
  • Colantonio LD; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, United States.
  • Levitan EB; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, United States.
  • Lloyd-Jones DM; Feinberg School of Medicine, Department of Preventive Medicine, Northwestern University, Chicago, IL, United States.
  • Cushman M; Department of Medicine, Larner College of Medicine, The University of Vermont, Burlington, VT, United States.
  • Muntner P; Office of Science, Center for Disease Control and Prevention, Atlanta, GA, United States.
  • Polonsky TS; Department of Medicine, University of Chicago, Chicago, IL, United States.
Am J Prev Cardiol ; 17: 100612, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38125204
ABSTRACT

Objective:

Age is the strongest contributor to 10-year predicted atherosclerotic cardiovascular disease (ASCVD) risk. Some older adults have a predicted ASCVD risk ≥7.5 %, without established risk factors. We sought to compare ASCVD incidence among adults with predicted ASCVD risk ≥7.5 %, with and without established ASCVD risk factors, to adults with predicted risk <7.5 %.

Methods:

We analyzed data from REasons for Geographic and Racial Differences in Stroke study participants, 45-79 years old, without ASCVD or diabetes, not taking statins and with low-density lipoprotein cholesterol 70-189 mg/dL. Participants were categorized into 3 groups based on their 10-year predicted ASCVD risk and presence of established risk factors <7.5 %, ≥7.5 % with established risk factors and ≥7.5 % without established risk factors. Established risk factors included smoking, systolic blood pressure ≥130 mmHg or antihypertensive medication use, total cholesterol ≥200 mg/dL, or high-density lipoprotein cholesterol <50 mg/dL for women (<40 mg/dL for men). Participants were followed for ASCVD events.

Results:

Among 11,115 participants, 911 incident ASCVD events occurred over a median of 11.1 years. ASCVD incidence rates were 3.6, 12.8, and 9.8 per 1,000 person-years for participants with predicted risk <7.5 %, predicted risk ≥7.5 % with established risk factors and predicted risk ≥7.5 % without established risk factors, respectively. Compared to adults with predicted risk <7.5 %, hazard ratios for incident ASCVD in participants with risk ≥7.5 % with and without established risk factors were 3.58 (95 %CI 3.03 - 4.21) and 2.72 (95 %CI 1.91-3.88), respectively.

Conclusions:

Adults with a 10-year predicted ASCVD risk ≥7.5 % but without established risk factors had a high ASCVD incidence.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Am J Prev Cardiol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Am J Prev Cardiol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos